Tourmaline Bio
AcquiredTourmaline Bio is a biotech company in United States.
- Business Model
- B2B
- Website
- tourmalinebio.com
- Acquisition Date
- Sep 2025
About
Late-stage clinical biotechnology company, now part of Novartis, that developed medicines intended to improve and extend patients' lives.
Exit History
Data from Indexed.vcUpdated
Sep 2025
Sign up to see all 2 events
Funding, valuations, and company events, with amounts and investors where available.
Similar Companies
Tiantan Biological / China Biologic (泰邦生物集团)
China's leading blood products manufacturer
Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tourmaline-bio"><img src="https://indexed.vc/api/badge/company/tourmaline-bio" alt="Tourmaline Bio on Indexed.vc" width="260" height="76" /></a>